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-Catenin/Tcf-4 signaling pathway plays important roles in colorectal tumorigenesis. RT-PCR, western 
blotting and immunoprecipitation were used to study the effects of curcumin on -catenin/Tcf-4 
signaling pathway in HT-29 cells. Treatment of curcumin could induce cleavage of -catenin and the 
cleavage could be inhibited by caspase inhibitors. The association of -catenin with Tcf-4 in nucleus 
could be inhibited by curcumin. The expression of c-myc and cyclinD1 was downregulated by 
curcumin, which could not be blocked by Z-DEVD-FMK. The results showed curcumin could induce the 
cleavage of -catenin by activition of caspases and downregulate the activity of -catenin/Tcf signaling 
pathway independent of the caspases in HT-29 cells. 
 





Colorectal cancer is one of the most common and poten-
tially fatal diseases in the world. Dysregulation of the Wnt 
signaling pathway is believed to play important roles in 
the pathogenesis of colorectal cancer (Polakis, 2000). In 
the absence of Wnt signal, -catenin can be phosphor-
rylated in the cytoplasm by axin-adenomatous polyposis 
coli (APC)-glycogen synthase kinase 3 (GSK3) com-
plex and be degraded by ubiquitin-proteasome pathway 
(Rubinfeld et al., 1996). When the Wnt pathway is 
activated, GSK3 is inhibited and -catenin is not phos-
phorylated any more and the level of cellular -catenin 
increases. Free -catenin can translocate to the nucleus, 
forming a complex with T-cell factor 4 (Tcf-4). This com-
plex then binds DNA and induces the expression of 
genes responsible for cell growth and proliferation such 
as c-myc, cyclin D1, c-Jun and VEGF (Staal et al., 2002; 
He et al., 1998; Tetsu and McCormick, 1999; Mann et al., 
1999). Mutations of the APC gene or serine-threonine 
phosphorylation sites for the GSK-3 within exon 3 of the 
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colorectal tumorigenesis (Morin et al., 1996). Humans 
who inherit mutant APC or -catenin develop thousands 
of benign tumors (adenomas) in colon, some of which 
progress to cancer. Recently, mutations in APC have 
been identified in up to 80% of ‘classic’ sporadic colo-
rectal cancers (Bright-Thomas and Hargest, 2003). This 
means that the dysregulation of -catenin plays a crucial 
role in colorectal cancer cells. Therefore if the transacti-
vation ability of -catenin/Tcf is significantly reduced, 
tumor growth may be suppressed. 
Curcumin is an important polyphenol extracted from the 
rhizomes of Curcuma longa L. Several studies have 
shown curcumin exerts antioxidant, anti-inflammatory, 
anti-carcinogenic and chemopreventive activities on 
many tumor cells (Shishodia et al., 2005). Curcumin can 
induce the apoptosis of many cancer cell lines such as 
SW480, HT-116, HL-60, K562, H520 and HeLa, which is 
mediated by caspase family (Bhaumik et al., 2000; Sen et 
al., 2005). Accumulating evidence suggests that cur-
cumin has a diverse range of molecular targets, which 
supports the notion that curcumin influences numerous 
biochemical and molecular cascades (Goel et al., 2008). 
Curcumin has been proved to be a potent inhibitor of the 
activation of various transcription factors including NF-B, 
AP-1, STAT, and PPAR-  (Aggarwal  et  al., 2006).  Cur- 




cumin can also down-regulate the activities of multiple 
kinases such as PKC, ERK1/ERK2, and JNK (Shishodia 
et al., 2007). The dysregulation of -catenin plays crucial 
roles in colon cancer cells. Several studies have showed 
that curcumin could inhibit the activity of -catenin/Tcf 
signaling pathway (Jaiswal et al., 2002; Park et al., 2005). 
Another study suggests that curcumin cannot affect the 
-catenin/Tcf signaling pathway (Bordonaro et al., 1999). 
It has been indicated that curcumin induces the cleavage 
of -catenin by activation of caspases in HCT-116 cells, 
but the reduction of transactivation ability induced by 
curcumin is independent of caspases (Jaiswal et al., 
2002). However, another study suggests that curcumin 
has no significant effects on the levels of -catenin in 
HCT-116 and SW480 cells (Park et al., 2005). We hypo-
thesize the mechanisms that curcumin reduces the -
catenin/Tcf transcriptional activity may be various in 
different cell lines. In the present study, we investigated 
whether curcumin could affect -catenin/Tcf signaling in 
HT-29 cells and further studied the mechanism for the 
cleavage of -catenin induced by curcumin. Our data 
suggests that curcumin can induce cleavage of -catenin 
by activation of caspases in HT-29 cells, inhibit the asso-
ciation of -catenin with Tcf-4 and down-regulate the 
expression of its downstream genes. 
 
 




RPMI-1640, fetal bovine serum (FBS), penicillin, streptomycin and 
trypsin were purchased from GIBCO. Curcumin, sodium dodecyl-
sulfate (SDS), dithiothreitol (DTT), phenylmethyl-sulfonylfluoride 
(PMSF) and bovine serum albumin (BSA) were purchased from 
Sigma-Aldrich Co. (St. Louis, MO, USA). Anti--catenin, anti-Tcf-4, 
anti-c-Myc, anti-cyclin D1 andhorseradish peroxidase-conjugated 
goat anti-rabbit antibodies were obtained from Epitomics. The cas-
pase inhibitors CBZ-Val-Ala-Asp-fluoromethylketone (ZVAD-FMK), 
CBZ-Asp-Glu-Val-Asp-fluoromethylketone (ZDEVD-FMK), Boc-Asp-
fluoro- methylketone (BD-FMK) and the cathepsin inhibitor CBZ-
Phe-Ala-fluoromethylketone (ZFA-FMK) were purchased from 
Biovision (Palo Alto, USA). Nitrocellulose membrane and the 
enhanced chemiluminescence (ECL) detection system were pur-
chased from Amersham (Pittsburgh, USA). Nuclear and Cyto-
plasmic Protein Extraction Kits were purchased from Beyotime 
Biotech, China. Reverse Transcription Kit was from Takara, Japan. 
Other reagents were of analytical grade and procured locally. 
 
 
Cell culture and treatment 
 
The human colon cancer cell line HT-29 was obtained from the 
American Type Culture Collection (Manassas, VA, USA) and 
maintained in RPMI 1640, supplemented with 10% fetal bovine 
serum, 100U/ml penicillin and 100 g/ml streptomycin at 37°C in a 
humidified atmosphere of 5% CO2 and 95% air. Upon reaching 70 - 




Isolation of whole cell extracts 
 





with ice-cold PBS. The total proteins were solubilized and extracted 
with 100 l lysis buffer (Tris 20 mM, pH 7.5, NaCl 150 mM, Triton X-
100 1%, sodium orthovanadate 1 mM, -glycerophosphate 100 M, 
EDTA 5 mM, sodium orthovanadate 0.2 mM, leupeptin 10 g/ml 
and PMSF 2 mM). The lysates were centrifugated at 15000 g for 10 
min and the supernatants were saved. The extracts were used to 
estimate their protein content using a BCA Protein Assay kit 
(Beyotime Institute of Biotechnology, China). 
 
 
Isolation of nuclear proteins 
 
Nuclear proteins were extracted as described elsewhere with minor 
modifications (Park et al., 2005). After treatment for 24 h, the cells 
were washed three times with ice-cold PBS and suspended in 100 
l lysis buffer (10 mM HEPES, pH 7.8, 10 mM KCl, 2 mM MgCl2 
and 0.1 mM EDTA). The cells were placed on ice for 15 min and 
then vortexed after the addition of 5 l of 10% Nonidet NP-40. After 
a 5 min centrifugation (16,000 g, 4°C ), the pelleted nuclei were 
resuspended in 100 l of extraction buffer (20 mM Hepes, pH 7.9, 
50 mM KCl, 400 mM NaCl, 1 mML EDTA, 1 mM EGTA, 1 mM DTT 
and 1 mM PMSF). After vigorously shaking at 4°C for 30 min, 
nuclear extracts were aliquoted and stored at - 70°C until use. 





The immunoprecipitation was done as previously described with 
minor modifications (Park et al., 2005). The nuclear lysates con-
taining 500g of protein were incubated with 5 g primary antibody 
overnight at 4°C. 50 l of protein A/G plus-agarose (Santa Cruz, 
USA) were added and the complexes were incubated at 4°C 
overnight. The beads were washed three times with high salt buffer 
(1 M Tris-HCl, pH 7.4, 0.5 M NaCl and1% Nonidet P-40) and twice 
with lysis buffer to eliminate nonspecific binding. The immuno-






Western blotting was performed as previously described with minor 
modifications to detect the expressions of -catenin, c-myc and 
cyclin D1 protein (Yan et al., 2009). 50 g of protein from each 
sample were subjected to electrophoresis on a 12% SDS-polyacry-
lamide gel. After electrophoresis, proteins were electroblotted to a 
Hybond-C Extra nitrocellulose membrane. The membranes were 
blocked at room temperature with 5% nonfat dry milk in TBS 
containing 0.3% Tween (TBS-T). The membranes were washed 
three times with TBS-T and incubated overnight at 4°C with rabbit 
monoclonal anti--catenin antibody (1:5,000), anti-c-myc antibody 
(1:10,000), or anti-cyclin D1 antibody (1:1,000) followed by 1 h 
incubation with the horseradish peroxidase-conjugated secondary 
antibody (1:5000 dilution). After incubation, the membranes were 
washed with TBS-T for three times, the antigen-antibody complexes 
were visualized by enhanced chemiluminescence. 
 
 
RNA extraction and reverse transcription (RT-PCR) 
 
RNA was extracted with Trizol Isolation Reagent (Invitrogen, USA). 
Sample RNA content was quantified by measuring absorbance at 
260 nm. RT-PCR was performed with PrimeScript RT-PCR Kit 
(Takara, Japan) according to the manufacturer's instructions. Table 
1 showed the primer sequences used for RT-PCR and the product 
sizes. -Actin served as an internal control. A total reaction volume 
of 20 l contained 4 l of reverse  transcription  product,  2.5 U  Taq  




Table 1. The synthetic primers used for RT-PCR. 
 
Genes Sense primer (5’3’) Antisense primer (5’3’) Size (bp) 
c-myc CAGCTGGAGATGGTGACCGAG TCTTGCGAGGCGCAGGACTTG 343 
Cyclin D1 ATAGGTGTAGGAAATAGCGCT TCCGGTGTGAAACATCTAAGA 345 






Figure 1. Curcumin induced cleavage of -catenin in HT-29 
cells. The whole cell extracts were immunoblotted with -
catenin antibody. To demonstrate equivalent loading of the 




DNA polymerase, 20 M dNTP, 0.1 M primer and 1× Taq DNA 
polymerase buffer (Takara, Japan). The reaction mixture was 
incubated in a thermocycler (Perkin-Elmer, CA, USA) programmed 
to pre-denature at 94°C for 10 min, denature at 94°C for 30 s, 
anneal at 55°C for 30 s and extend at 72°C for 1 min. The last cycle 
was followed by incubation at 72°C for 10 min and cooling to 4°C. 
The optimum cycle number that fell within the exponential range of 
response for c-myc (25 cycles), cyclin D1 (28 cycles), or -actin (22 






The student’s t-test was used to determine significant differences 





-catenin was cleaved by curcumin and caspase 
family inhibitors blocked the cleavage of -catenin in 
HT-29 cells 
 
We performed western blotting to investigate the effects 
of curcumin on the level of -catenin in HT-29 cells. The 
whole cell extracts derived from HT-29 cells were used to 
western blotting with -catenin antibody. One truncated 
-catenin fragments were detected in the curcumin 
treated cells (Figure 1). This meant that curcumin could 
activate the cleavage of -catenin.  
The caspase family play important roles in curcumin-
mediated apoptosis. There are also studies indicated that 
caspases could cleave the -catenin to several fragments 
(Steinhusen et al., 2000). To determine whether cas-
pases are involved in the curcumin-mediated cleavage of 
-catenin, we studied the effects of various caspase 
family inhibitors. The most  effective  nhibiting  concentra- 
catenin cleavage was inhibited by caspase inhibitors
 
 
Figure 2. Curcumin induced -catenin cleavage was inhibited 




tions of the inhibitors were determined for our assay. In 
this study, all the inhibitors were used at the concentra-
tion of 20 M. Curcumin induced -catenin cleavage was 
inhibited by the caspase inhibitors such as ZDEVD-FMK, 
ZVAD-FMK and BD-FMK (Figure 2). The cathepsin inhi-
bitor ZFA-FMK was used as a control for the FMK group 
and found not to block -catenin cleavage (Figure 2). 
This result indicated curcumin induced -catenin clea-
vage was mediated by the caspase family.  
HT-29 cells were pre-incubated for 30 min with 20 M 
of ZVAD-FMK, ZDEVD-FMK or BD-FMK and then treated 
with 40 M of curcumin for an additional 12 h. The 
cathepsin inhibitor ZFA-FMK (20 M) was used as a 
negative control reagent for peptide-FMKs. 
 
 
Curcumin decreased the level of -catenin and 
inhibited the association of -catenin with Tcf-4 in the 
nucleus of HT-29 cells 
 
The level of -catenin and the association of -catenin 
with Tcf-4 in the nucleus are very important for the acti-
vation of -catenin/Tcf signaling pathway (Polakis, 2000). 
We treated HT-29 cells with curcumin (0 - 80 M) and 
then determined the level of -catenin protein in nucleus 
by western blotting. Our results showed that the amounts 
of -catenin in the nucleus of HT-29 cells were markedly 
reduced by curcumin in a dose-dependent manner 
(Figure 3a). The association of -catenin with Tcf-4 is 
required for  activation  of  Tcf  signaling,  so  we  studied  






Figure 3. Curcumin inhibited the association of -catenin with Tcf-4 in nucleus. (a) 50 g 
protein extracted from nucleus were used to determine the level of -catenin by western 
blotting. -catenin/Tcf-4 complexes were immunoprecipitated from nuclear extracts with Tcf-4 
antibody followed by immunoblotting with -catenin monoclonal antibody. (b) HT-29 cells 
were pretreated with or without 20 M Z-DEVD-FMK for 30 min and then were incubated with 
or without 60 M curcumin for 24 h. IP and IB were performed to determine the level of -





(a) (b)  
 
Figure 4. Curcumin downregulated the expression of c-myc. (a) The total RNA was extracted and RT-PCR 
was performed. -actin was used as an internal control. (b) The HT-29 cell lysates were immunoblotted with 




whether curcumin could affect the formation of the com-
plex -catenin with Tcf-4. We used anti-Tcf-4 antibody to 
coimmunoprecipitate the -catenin/Tcf-4 complex from 
nuclear extracts and then we determined the amount of 
-catenin by immunobloting. Figure 3a showed the level 
of Tcf-4/-catenin complex in nucleus was significantly 
decreased by the incubation of 20 - 80 M curcumin. The 
decreased level of -catenin/Tcf-4 complex was not been 
changed by Z-DEVD-FMK (Figure 3b). From this result, 
we can conclude that curcumin inhibits the formation of -
catenin/Tcf-4 complex, which is independent of caspase-
3 activation. IP and IB were performed to determine the 
level of -catenin/Tcf-4 complex.  
 
 
Curcumin down-regulated the -catenin/Tcf signaling 
pathway  
 
-Catenin can translocate into the nucleus (Molenaar et 
al., 1996), where it associates with Tcf-4 and regulates 
the expression of downstream targets such as c-myc and 
cyclin D1. These proteins are very important for the 
growth and proliferation of cancer cells. Oncogene c-myc 
plays important roles in many cellular events and the over 
expression of c-myc is related to the increase of cell 
proliferation in a variety of malignant tumors. c-myc is a 
target of -catenin/Tcf-4 signaling pathway, so we hypo-
thesized that the expression of c-myc might be down-
regulated by treatment of curcumin. The present results 
showed the level of c-myc transcript was reduced by 
treatment of curcumin (Figure 4a). Western blotting 
results also indicated that the amount of c-myc was 
markedly decreased in the curcumin treated cells (Figure 
4b).  
Cyclin Dl, another well known target of -catenin/Tcf-4, 
plays important roles in regulating the cellular progress-
sion through the G1 phase of the cell cycle (Arber et al., 
1997). In this study, we investigated the effects  of  curcu- 




(a) (b)  
 
Figure 5. Curcumin reduced the expression of cyclin D1. (a) Semi-quantative RT-PCR was performed to 











min on the expression of cyclin D1. Our results indicated 
that the levels of cyclin D1 transcript were markedly 
decreased when the cells were treated with 40 - 80 M 
curcumin (Figure 5a). Western blotting results showed 
treatment of curcumin dose-dependently reduced the 
amount of cyclin D1 in HT-29 cells (Figure 5b).  
 
 
Z-DEVD-FMK could not inhibited down-regulation of 
c-myc and cyclin D1 induced by curcumin in HT-29 
cells 
 
On the basis of the results that Z-DEVD-FMK pretreat-
ment could not block the decrease of -catenin/Tcf-4 
complex induced by curcumin, we hypothesized the 
transactivation ability of -catenin/Tcf complex would not 
be affected by Z-DEVD-FMK pretreatment. To test this 
idea, we pretreated HT-29 cells with 20 M Z-DEVD-FMK 
and then incubated the cells with 60 M curcumin for 24 
h. The western blotting results showed that the decrease 
of c-myc and Cyclin D1 induced by curcumin were not 





Curcumin can strongly inhibit growth of various colon 
cancer cell lines, but the underlying molecular mecha-
nisms remain unknown. Our work had two interesting 
findings. First, curcumin induced the cleavage of -
catenin in HT-29 cellular extracts, which was mediated by 
caspases. Second, curcumin markedly down-regulated 
the activity of -catenin/TCF-4 signaling pathway and 
decreased the expression of the downstream targets 
such as c-myc and cyclin D1 in HT-29 cell, which was not 
been affected by the caspase-3 inhibitor, Z-DEVD-FMK. 
-Catenin plays important roles in the apoptosis or 
survival of cancer cells. Jaiswal et al. (2002) suggested 
that curcumin treatment induced cleavage of -catenin in 
HCT-116 cells. However, Park et al. (2005) reported that 
the amount of -catenin had not been affected by 
curcumin and its derivative in HCT-116 and SW480 cells. 
The discrepancy in their reports is perhaps due to 
following two reasons: First, the time period of curcumin 
treatment was the important difference in HCT-116 cells. 
The time of treatment was restricted to 24 h in the study 
of Park et al. (2005); 30 h was used in the study of 
Jaiswal et al. (2002). Second, there might be different 
influences between HCT-116 and SW480 cell lines when 
the cells were treated with curcumin. In previous studies, 
it had been suggested that the cleavage of -catenin 
induced by curcumin may be mediated by caspase-3 in 
HCT-116 (Jaiswal et al., 2002). In this study, we found 
treatment with 20-80 M of curcumin for 24 h could 
induce -catenin cleaved into two fragments in HT-29 
cells, which was consistent with the results obtained in 
HCT-116 cell line (Jaiswal et al., 2002). It had been 
indicated that curcumin can activate caspase family in 
many cancer cell lines (Bhaumik et al., 2000; Sen et al., 
2005). We had found curcumin could activate the cas-
pases in HT-29 cells (Wang et al., 2009). In the present 
study, we used caspase inhibitors to study whether 
curcumin induced the cleavage of -catenin was 
mediated by caspases. In congruence  with  the  previous  




findings (Jaiswal et al., 2002), we found caspase inhi-
bitors blocked curcumin induced cleavage of -catenin in 
HT-29 cells, which suggested that the cleavage of -
catenin induced by curcumin was mediated by caspases 
in HT-29 cells. 
It is very important that -catenin translocates into 
nucleus and associates with Tcf-4 for growth and 
proliferation of many cancer cells. So we determined the 
effects of curcumin on the levels of -catenin and -
catenin/Tcf-4 complex in HT-29 cell nucleus. Consistent 
with previous findings of Park et al. (2005), our data 
showed curcumin decreased the level of the -
catenin/Tcf-4 complex in HT-29 cell nucleus. We next 
studied the effects of Z-DEVD-FMK on the level of -
catenin in nucleus. Our results indicated pretreatment of 
HT-29 cells with Z-DEVD-FMK blocked the reduction of 
the level of -catenin/Tcf-4 complex in nucleus. 
In several colorectal cancer cell lines, the binding of -
catenin/Tcf-4 complex to DNA activates the expression of 
many genes relevant to colon carcinogenesis, such as c-
myc and cyclin D1. c-myc is a well-known oncogene 
which promotes cell growth and transformation as well as 
vascular and hematopoietic development (He et al., 
2008). Downregulation of c-myc can suppress the growth 
and proliferation of many cancer cells (Schorl and Sedivy, 
2003). Increased nuclear expression of cyclin D1 occurs 
in around one third of colonic tumors as an early event 
during multistage process of colon carcinogenesis (Arber 
et al., 1996). Overexpression of anti-sense cyclin D1 
cDNA inhibits the growth of SW480 colon cancer cells in 
nude mice, indicating a critical role for cyclin D1 in tumo-
rigenesis (Arber et al., 1997). To further clarify the effects 
of curcumin on -catenin/Tcf-4 signaling pathway, we 
studied the expression changes of these downstream 
genes in curcumin treated HT-29 cells. Our results 
showed curcumin down-regulated the expression of c-
myc and cyclinD1. The decrease in the levels of c-myc 
and cyclinD1 was not blocked by the pretreatment with Z-
DEVD-FMK, which indicated the down-regulation of -
catenin/Tcf-4 transactivation ability was independent of 
caspases activation. 
It is interesting to note that although curcumin induced 
cleavage of -catenin was blocked by pretreatment with 
Z-DEVD-FMK in HT-29 cells; the level of the -
catenin/Tcf-4 complex in nucleus was not reduced. We 
believe there are two possible reasons. First, either -
catenin or Tcf-4 or both could be directly modified by 
curcumin in a way and such modification inhibits their 
association. A second possible explanation is that curcu-
min may induce a protein(s) that somehow inhibits the 
formation of -catenin/Tcf-4 complex. 
In summary, the present study shows curcumin can 
induce cleavage of -catenin in HT-29 cells by activation of 
caspases. The association of -catenin with Tcf-4 was 
inhibited by curcumin independent of caspases. The main 
targets of -catenin/Tcf-4 signaling pathway in HT-29 cells 
have also been downregulated by curcumin treatments. 





differentiation and neovascularization of colorectal cancer 
cells. Based on these findings, we suggest that curcumin 
may play anti-tumor role by repression of -catenin/Tcf-4 
signaling pathway. In the future, curcumin may prove an 
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